Screener
NeoGenomics NEO Reportable Segment — Sales and marketing
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NeoGenomics in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The source filing: NeoGenomics’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001077183-26-000059
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Other cost of revenue(1) | 101,831 | 95,525 | 199,715 | 181,342 |
| Other general and administrative(1) | 48,569 | 52,836 | 97,614 | 103,585 |
| Other research and development(1) | 9,934 | 7,859 | 18,393 | 16,961 |
| Other sales and marketing(1) | 26,666 | 23,217 | 50,142 | 44,927 |
| Impairment charges | — | 20,041 | — | 20,041 |
| Loss from operations | (9,771) | (47,628) | (28,012) | (75,453) |
| Interest income | 1,214 | 2,263 | 2,487 | 5,984 |
| Interest expense | (781) | (933) | (1,379) | (2,551) |
Item 1. Financial Statements (unaudited)
FAQ
- What is NeoGenomics's reportable segment — sales and marketing?
- NeoGenomics (NEO) reported reportable segment — sales and marketing of $26.67M in Q2 2026.
- How has NeoGenomics's reportable segment — sales and marketing changed year-over-year?
- NeoGenomics's reportable segment — sales and marketing increased by 14.9% year-over-year, from $23.22M to $26.67M.
- What is the long-term trend for NeoGenomics's reportable segment — sales and marketing?
- Over 3 years (2022 to 2025), NeoGenomics's reportable segment — sales and marketing has grown at a 9.7% compound annual growth rate (CAGR), from $67.32M to $88.83M.
- What does reportable segment — sales and marketing mean?
- Costs incurred to promote services, acquire new clients, and maintain relationships with healthcare providers and pharmaceutical partners. This metric indicates the segment's investment in market penetration and customer acquisition efficiency.
Ask your AI about NeoGenomics's reportable segment — sales and marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude